DIANE OFILI: Open Payments
NPI 1619217387 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 11 payments from 7 companies in 2025. Trend: 2023 $219 · 2024 $828 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Davol Inc. | 1 | $154 |
| Baxter Healthcare | 1 | $122 |
| Novo Nordisk Inc | 3 | $77 |
| Currax Pharmaceuticals LLC | 2 | $35 |
| Lilly USA, LLC | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: Phasix Mesh, PERCLOT, Wegovy, CONTRAVE, INJECTAFER, ACCRUFER, MOUNJARO, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
